Search results
Cary firm part of $5B federal program to develop Covid-19 vaccines - Triad Business Journal
The Business Journals· 4 days agoThe federal government has selected a contract research organization in the Triangle to lead part of...
Study shows vaccination lowers risk of long COVID
Center for Infectious Disease Research and Policy· 3 days agoCOVID-19 patients vaccinated against the novel coronavirus were less likely to have symptoms of post-COVID condition (PCC), or long COVID, according to...
A citizen journalist imprisoned for ‘provoking trouble’ by reporting on COVID in China is released
Seattle Times· 3 days agoZhang Zhan, a citizen journalist, was released from prison after serving four years for charges...
Cracking the genetic code for COVID-19 vaccine effectiveness
Medical Xpress· 3 days agoHLA genes play a crucial role in the immune system's ability to recognize and respond to foreign...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 2 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
China’s top Covid expert is already preparing for the next pandemic. Here’s why
South China Morning Post· 5 days agoIn 2020, Zhang was appointed leader of Shanghai’s clinical expert team for Covid-19, becoming a...
NHL partnering with New York City Gay Hockey Association’s Chelsea Challenge | NHL.com
NHL· 3 days agoThe centerpiece is the NHL shield logo colored with the six common variants of the rainbow (red,...
Did NIH officials hide COVID-19 records?
The Hill· 2 days agoThe memo claims Morens unlawfully deleted emails and used a “secret back channel” to evade transparency. Rep. Rich McCormick, R-Ga., and former CDC...
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 5 days agoThe efficacy of ARCT-154 against severe COVID-19 was 100 percent in healthy persons aged 18-59 and more than 90 percent in persons at risk of severe consequences ...
Trials that infected people with common colds can inform today’sCOVID-19 challenge trials
Nature· 5 days agoLetter to the Editor
